HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gentamicin pharmacokinetics in adults with bacterial endocarditis.

Abstract
The pharmacokinetics of gentamicin in adult patients with endocarditis were studied. The records were reviewed for 64 patients treated for bacterial endocarditis and for whom serum gentamicin concentrations had been requested between May 1990 and May 1993. The patients were divided into those with serum creatinine concentration (SCr) <1.2 mg/dL and those with SCr > or = 1.2 mg/dL. The measured serum gentamicin concentrations, patient demographic information, dosage interval, and SCr were entered into a pharmacokinetics program for analysis. The pharmacokinetic values evaluated were steady-state distribution volume (V), clearance (CL), elimination rate constant (k), and half-life (t1/2). The mean +/- S.D. t1/2 and V of gentamicin were 4.7 +/- 2.4 hr and 0.29 +/- 0.11 L/kg. Half-life was correlated with SCr and V. These two variables may explain 66% of the variation in t1/2. No difference in V was observed between patients with normal versus abnormal SCr. Men had a lower k than women. V and CL were lower in patients under age 60 than in older patients. Adult patients with endocarditis may have expanded gentamicin V. V and CL accounted for most of the variation in gentamicin t1/2.
AuthorsM L Rosell-Rovira, L Pou-Clavé, L García-Beltran, C Pascual-Mostaza
JournalAmerican journal of hospital pharmacy (Am J Hosp Pharm) Vol. 51 Issue 11 Pg. 1429-32 (Jun 01 1994) ISSN: 0002-9289 [Print] United States
PMID7942877 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Gentamicins
  • Creatinine
Topics
  • Adult
  • Creatinine (blood)
  • Endocarditis, Bacterial (metabolism)
  • Female
  • Gentamicins (administration & dosage, pharmacokinetics)
  • Half-Life
  • Humans
  • Male
  • Metabolic Clearance Rate
  • Middle Aged
  • Retrospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: